Understanding
Regenerative
Options
Three categories, explained clearly: what they are, how they’re used, and what a visit typically looks like.
Regenerative Categories — Practical Overview
This page is written for clinics evaluating regenerative additions. It outlines three categories in plain language: what each category is, how it is typically used in a clinical workflow, and the documentation standards that protect credibility during patient education. The intent is straightforward: help your team speak with clarity and avoid marketing-grade ambiguity.
Extracellular Matrix (ECM) Allograft (EXM)
Positioning note: EXM is commonly framed as a structural/supportive scaffold (cushioning/covering/support) used under a licensed provider’s direction for intended homologous use. Avoid “miracle” language. Anchor the conversation in structure + handling + documentation.
In clinic terms
ECM is a flowable, cryopreserved allograft derived from structural proteins. Clinically, it is positioned as a supportive environment — a scaffold/cushion/cover that can help tissue organize. The operational focus is on appropriate use, placement context, and protocol discipline.
Typical administration workflow
- In-office procedure performed by a licensed provider
- Targeted placement into soft tissue based on assessment (not into the spinal canal)
- Local comfort measures; brief soreness is commonly discussed (24–72 hours)
Common fit inside a practice
- Soft-tissue interfaces where cushioning/covering/support is clinically appropriate
- Adjunctive use when conservative care has not achieved the desired response
- Patients seeking minimally invasive options before escalating to more invasive pathways
Operational expectations
- Assessment → prep → placement (minutes) → brief observation
- Clear after-care guidance and short activity modifications when indicated
Common intended-context examples (high-level)
- Musculoskeletal support: adjunctive cushioning/covering at soft-tissue interfaces under provider direction.
- Paraspinal soft tissue: supportive placement near symptomatic soft tissues, per clinical evaluation.
- Post-procedure soft-tissue support: covering/cushioning of tissue surfaces where intended.
- Dermal/soft-tissue covering: providing a protective scaffold where clinically appropriate.
Clinic-facing notes (what your team should say)
- Primary framing: support/scaffold/cushion/cover — not “treating” a disease.
- Expectation discipline: individualized planning; avoid timeline guarantees.
- Credibility driver: chain-of-custody, lot documentation, thaw instructions, intended use statement.
Topical Exosome Adjuncts (EXO) — Cosmetic Use
Positioning note: EXO is presented as a professional topical adjunct applied to intact skin during aesthetic workflows (e.g., microneedling/laser/dermabrasion). This is not an injectable/IV/systemic category.
In clinic terms
These are topical vials used in a professional setting to support appearance-oriented outcomes (tone/texture) as part of a post-procedure routine. The practical value for a clinic is protocol consistency, clear scope, and integration into existing aesthetic pathways.
Typical administration workflow
- Applied topically by trained staff
- Often paired with microneedling, laser, or dermabrasion protocols
- No injections or IV; positioned as a skin-surface adjunct
Common fit inside a practice
- Patients seeking appearance support within a cosmetic plan
- Adjunctive step to enhance patient experience during aesthetic recovery
Operational expectations
- Procedure → topical application → after-care instructions
- Post-procedure skin guidance becomes part of the protocol standard
Where this is used (examples)
- Post-procedure skin care: adjunct after microneedling, laser, dermabrasion on intact skin.
- Tone/texture support: professional topical step during recovery protocols.
- Scalp aesthetics: applied with professional scalp protocols on intact skin.
Clinic-facing notes (what your team should say)
- Scope clarity: cosmetic use on intact skin only.
- Workflow clarity: applied by staff, paired with aesthetic procedures, supported by after-care guidance.
- Credibility driver: storage/handling specifics, sterility testing where applicable, manufacturer quality summary.
Topical Cellular Support (EXS) — Cosmetic Adjunct
Positioning note: EXS is presented as a protocol-driven topical step that supports comfort and appearance on intact skin. Keep language clean: complementary, non-invasive, professional use.
In clinic terms
A topical preparation used during the finish stage of an aesthetic visit or follow-up. The practical goal is to support the clinic’s post-procedure routine and provide a consistent, repeatable step that is easy for patients to understand.
Typical administration workflow
- Applied at the end of an aesthetic visit or during follow-up
- Used on intact skin only; no injections or IV
Common fit inside a practice
- Patients who want non-invasive add-ons without downtime
- Post-procedure routines where comfort and hydration support are emphasized
Operational expectations
- Quick application; after-care guidance standardized
- Repeatable per plan when clinically appropriate
Where this is used (examples)
- Procedure after-care: professional topical used on intact skin following aesthetic treatments.
- Comforting support: complements protocols aimed at maintaining a calm, hydrated skin environment.
Clinic-facing notes (what your team should say)
- Scope clarity: cosmetic support only; not intended to treat medical conditions.
- Protocol clarity: storage, handling, device compatibility (if paired) should be standardized.
- Credibility driver: shelf-life, handling requirements, and consistent after-care instructions.
Quick Comparison (Clinic-Facing)
This table is meant to help staff explain scope and intended context quickly — especially when patients confuse categories. The goal is clarity: what is structural/homologous under provider direction vs. what is topical cosmetic adjunct.
| Category | Intended context | Supply/format | Operational notes |
|---|---|---|---|
| ECM Allograft (EXM) | Homologous use (structure/cushioning/support) under licensed provider | Cryopreserved, flowable; common volumes ~1–2 cc; glycerol or DMSO cryoprotectant | Chain-of-custody + lot documentation + thaw instructions should be standardized and retrievable |
| Topical Exosome Adjunct (EXO) | Professional cosmetic use on intact skin | Topical vials for clinic application | Used with microneedling/laser/dermabrasion; not for injection/IV/systemic use |
| Topical Cellular Support (EXS) | Professional cosmetic use on intact skin | Topical preparation; protocol-driven | Storage/handling and pairing steps should be written into protocol; not for injection/IV/systemic use |
Documentation Standards to Normalize
This is where clinics win trust. Patients are exposed to marketing. Your clinic should be able to answer with lot-specific documentation, handling protocols, and scope clarity — in writing.
For EXM (ECM allograft)
- Donor eligibility screening summary
- Chain-of-custody and lot information
- Cryoprotectant used (e.g., glycerol or DMSO) and thaw instructions
- Intended homologous use statement
For EXO/EXS (topical cosmetic)
- Statement of topical cosmetic use only on intact skin
- Manufacturing/quality summary and sterility testing where applicable
- Storage, handling, and shelf-life specifics
- Procedure pairing guidance and after-care protocol
Important Scope & Use Notes (Clinic-Facing)
- ECM allografts (EXM): intended for homologous use under a licensed provider’s direction; not approved to diagnose, treat, cure, or prevent disease.
- Topical adjunct categories (EXO/EXS): for cosmetic use on intact skin only; not for injection, IV, or systemic use.
Educational material only. This document is intended to support clinic education and patient communication clarity. Clinical judgment, local policy, and provider protocols determine suitability and use.
Explore More Across OriGen Clinics
Browse treatments, stem cell education, clinic resources, and the main pages across the site.
See If Regenerative Medicine Fits Your Clinic
Explore whether stem cell–based therapies align with your clinic’s current services, patient model, and growth goals. Start with a quick clinic fit assessment or schedule a consultation to review integration possibilities.